Study results show linaclotide reduces IBS-C symptoms

10/13/2008 | Medscape (free registration)

Phase IIb study results presented at the ACG annual meeting show linaclotide improves abdominal pain, relieves constipation and helps reduce other symptoms in adults with irritable bowel syndrome with constipation. Study data show patients found relief within one week of beginning treatment.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD